CL - Colgate-Palmolive Company

$91.03 2.18 (-2.34%) Last updated: Jul 15, 2026 04:25

52-Week Range

$91.03

$74.55 $91.03 $99.33

Fundamentals Overview

Colgate-Palmolive Company is in the middle of its 52-week range with premium valuation, trending downward today.

Valuation premium

P/E 35.1 P/B 503.68 P/S 3.5

Intrinsic value (DCF)

+4.7% upside vs price

Profitability

Net margin 10%

Risk (Beta)

0.32 — lower vol

Earnings & growth

EPS $2.59 Rev +1.8% Profit +1845.9% vs prior qtr

BullzEye Analysis

Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Buy — 66% confidence Risk: Lower Volatility — Beta 0.32. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Analyst grade: B+ · Sentiment improving (4 upgrades) · 3M vs Consumer Defensive sector: +6.7%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$72.84B

P/E (TTM)

35.12

EPS (TTM)

$2.59

Dividend Yield

2.3%

52-Week Range

$74.55 - $99.33

Volume vs Avg

N/A

Beta

0.32

About

Operating globally, Colgate-Palmolive Company and its affiliated entities are engaged in the production and distribution of a diverse range of consumer goods. Its operations are structured into two primary divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care division encompasses a broad array of offerings, spanning oral hygiene (e.g., toothpastes, toothbrushes, mouthwashes), personal care (e.g., bar and liquid soaps, shower gels, shampoos, conditioners, de...

Sector: Consumer Defensive

Headquarters: US

Employees: 33,600

IPO Date: May 1973

Website: www.colgatepalmolive.com

Beta: 0.32 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 10, Equal Weight: 7, Hold: 2, Outperform: 2, Overweight: 9.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $95.30; current price is $91.03. That’s a +4.7% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric	Value
Valuation
P/E (TTM)	35.12
DCF value (model)	$95.30 (4.7% upside)
PEG (TTM)	N/A
P/B (TTM)	503.68
P/S (TTM)	3.5
P/FCF (TTM)	19.34
Liquidity & enterprise
Current Ratio (TTM)	1.02
Quick Ratio (TTM)	0.67
Cash Ratio (TTM)	0.22
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	10.04%
Gross margin (TTM)	60.06%
Operating margin (TTM)	21.21%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for CL.

Analyst Sentiment at a Glance

B+ Sentiment Improving

Buy 10Equal Weight 7Hold 2Outperform 2Overweight 9

4 upgrades, 0 downgrades

Price Target Consensus

Current $91.03

Median $99.50

Consensus $96.30

Low consensus $79.00

High consensus $102.00

Stock Grades (Institutions)

Institution	Action	Previous Grade	New Grade	Date
Piper Sandler	maintain	Overweight	Overweight	2026-07-09
Wells Fargo	maintain	Equal Weight	Equal Weight	2026-07-08
Barclays	maintain	Equal Weight	Equal Weight	2026-05-05
JP Morgan	maintain	Overweight	Overweight	2026-05-04
RBC Capital	maintain	Outperform	Outperform	2026-05-04
UBS	maintain	Buy	Buy	2026-05-04
Morgan Stanley	maintain	Overweight	Overweight	2026-04-23
Rothschild & Co	upgrade	Neutral	Buy	2026-04-21
Rothschild& Co	upgrade	Neutral	Buy	2026-04-21
JP Morgan	maintain	Overweight	Overweight	2026-04-17
Barclays	maintain	Equal Weight	Equal Weight	2026-04-14
B of A Securities	maintain	Buy	Buy	2026-04-10
Piper Sandler	maintain	Overweight	Overweight	2026-04-08
Wells Fargo	maintain	Equal Weight	Equal Weight	2026-04-08
UBS	maintain	Buy	Buy	2026-04-07
Deutsche Bank	upgrade	Hold	Buy	2026-03-30
Barclays	maintain	Equal Weight	Equal Weight	2026-02-03
Deutsche Bank	maintain	Hold	Hold	2026-02-02
Citigroup	maintain	Buy	Buy	2026-02-02
Morgan Stanley	maintain	Overweight	Overweight	2026-02-02
Piper Sandler	maintain	Overweight	Overweight	2026-02-02
JP Morgan	maintain	Overweight	Overweight	2026-02-02
Jefferies	maintain	Hold	Hold	2026-02-02
Evercore ISI Group	maintain	Outperform	Outperform	2026-02-02
Wells Fargo	maintain	Equal Weight	Equal Weight	2026-02-02
B of A Securities	maintain	Buy	Buy	2026-02-02
JP Morgan	maintain	Overweight	Overweight	2026-01-16
UBS	maintain	Buy	Buy	2026-01-14
Wells Fargo	upgrade	Underweight	Equal Weight	2026-01-13
TD Cowen	maintain	Buy	Buy	2026-01-08